Complement factor B is the downstream effector of TLRs and plays an important role in a mouse model of severe sepsis

Journal of Immunology

Volumn 191, Issue 11, 2013, Pages 5625-5635

  Zou, Lin ^a   Feng, Yan ^a   Li, Yan ^a   Zhang, Ming ^a   Chen, Chan ^a   Cai, Jiayan ^a   Gong, Yu ^a   Wang, Larry ^b   Thurman, Joshua M ^c   Wu, Xiaobo ^d   Atkinson, John P ^d   Chao, Wei ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; CASPASE 3; COMPLEMENT COMPONENT C3; MYELOID DIFFERENTIATION FACTOR 88; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL LOAD; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HEART; HEART FUNCTION; HEART MUSCLE CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIDNEY; LIGATION; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PERITONEAL CAVITY; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; PROTEIN SYNTHESIS; PUNCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; SIGNAL TRANSDUCTION; SURVIVAL; UPREGULATION;

EID: 84888371687     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301903     Document Type: Article

References (61)

1. Bone, R. C., R. A. Balk, F. B. Cerra, R. P. Dellinger, A. M. Fein, W. A. Knaus, R. M. Schein, and W. J. Sibbald. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101: 1644-1655.
2. Dombrovskiy, V. Y., A. A. Martin, J. Sunderram, and H. L. Paz. 2007. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit. Care Med. 35: 1244-1250.
3. Parrillo, J. E. 2008. Septic shock-vasopressin, norepinephrine, and urgency. N. Engl. J. Med. 358: 954-956.
4. Angus, D. C., W. T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M. R. Pinsky. 2001. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29: 1303-1310.
5. Medzhitov, R. 2007. Recognition of microorganisms and activation of the immune response. Nature 449: 819-826.
6. Markiewski, M. M., and J. D. Lambris. 2007. The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am. J. Pathol. 171: 715-727.
7. Ricklin, D., G. Hajishengallis, K. Yang, and J. D. Lambris. 2010. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 11: 785-797.
8. Medzhitov, R., and C. Janeway, Jr. 2000. The Toll receptor family and microbial recognition. Trends Microbiol. 8: 452-456.
9. Alves-Filho, J. C., A. Freitas, F. O. Souto, F. Spiller, H. Paula-Neto, J. S. Silva, R. T. Gazzinelli, M. M. Teixeira, S. H. Ferreira, and F. Q. Cunha. 2009. Regulation of chemokine receptor by Toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis. Proc. Natl. Acad. Sci. USA 106: 4018-4023.
10. Zou, L., Y. Feng, Y. J. Chen, R. Si, S. Shen, Q. Zhou, F. Ichinose, M. Scherrer-Crosbie, and W. Chao. 2010. Toll-like receptor 2 plays a critical role in cardiac dysfunction during polymicrobial sepsis. Crit. Care Med. 38: 1335-1342.
11. Cavassani, K. A., M. Ishii, H. Wen, M. A. Schaller, P. M. Lincoln, N. W. Lukacs, C. M. Hogaboam, and S. L. Kunkel. 2008. TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J. Exp. Med. 205: 2609-2621.
12. Alves-Filho, J. C., A. de Freitas, M. Russo, and F. Q. Cunha. 2006. Toll-like receptor 4 signaling leads to neutrophil migration impairment in polymicrobial sepsis. Crit. Care Med. 34: 461-470.
13. Roger, T., C. Froidevaux, D. Le Roy, M. K. Reymond, A. L. Chanson, D. Mauri, K. Burns, B. M. Riederer, S. Akira, and T. Calandra. 2009. Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4. Proc. Natl. Acad. Sci. USA 106: 2348-2352.
14. Plitas, G., B. M. Burt, H. M. Nguyen, Z. M. Bamboat, and R. P. DeMatteo. 2008. Toll-like receptor 9 inhibition reduces mortality in polymicrobial sepsis. J. Exp. Med. 205: 1277-1283.
15. Matsumoto, M., W. Fukuda, A. Circolo, J. Goellner, J. Strauss-Schoenberger, X. Wang, S. Fujita, T. Hidvegi, D. D. Chaplin, and H. R. Colten. 1997. Abrogation of the alternative complement pathway by targeted deletion of murine factor B. Proc. Natl. Acad. Sci. USA 94: 8720-8725.
16. Singh, M. V., A. Kapoun, L. Higgins, W. Kutschke, J. M. Thurman, R. Zhang, M. Singh, J. Yang, X. Guan, J. S. Lowe, et al. 2009. Ca2+/calmodulin- dependent kinase II triggers cell membrane injury by inducing complement factor B gene expression in the mouse heart. J. Clin. Invest. 119: 986-996.
17. Thurman, J. M., P. A. Royer, D. Ljubanovic, B. Dursun, A. M. Lenderink, C. L. Edelstein, and V. M. Holers. 2006. Treatment with an inhibitory monoclonal antibody to mouse factor B protects mice from induction of apoptosis and renal ischemia/reperfusion injury. J. Am. Soc. Nephrol. 17: 707-715.
18. Zhang, X., Y. Kimura, C. Fang, L. Zhou, G. Sfyroera, J. D. Lambris, R. A. Wetsel, T. Miwa, and W. C. Song. 2007. Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Blood 110: 228-236.
19. Fang, C., X. Zhang, T. Miwa, and W. C. Song. 2009. Complement promotes the development of inflammatory T-helper 17 cells through synergistic interaction with Toll-like receptor signaling and interleukin-6 production. Blood 114: 1005-1015.
20. Kaczorowski, D. J., A. Afrazi, M. J. Scott, J. H. Kwak, R. Gill, R. D. Edmonds, Y. Liu, J. Fan, and T. R. Billiar. 2010. Pivotal advance: The pattern recognition receptor ligands lipopolysaccharide and polyinosine-polycytidylic acid stimulate factor B synthesis by the macrophage through distinct but overlapping mechanisms. J. Leukoc. Biol. 88: 609-618.
21. Hajishengallis, G., and J. D. Lambris. 2010. Crosstalk pathways between Toll-like receptors and the complement system. Trends Immunol. 31: 154-163.
22. Goring, K., Y. Huang, C. Mowat, C. Leger, T. H. Lim, R. Zaheer, D. Mok, L. A. Tibbles, D. Zygun, and B. W. Winston. 2009. Mechanisms of human complement factor B induction in sepsis and inhibition by activated protein C. Am. J. Physiol. Cell Physiol. 296: C1140-C1150.
23. Younger, J. G., D. O. Bracho, H. M. Chung-Esaki, M. Lee, G. K. Rana, A. Sen, and A. E. Jones. 2010. Complement activation in emergency department patients with severe sepsis. Acad. Emerg. Med. 17: 353-359.
24. Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, and S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11: 443-451.
25. Yamamoto, M., S. Sato, H. Hemmi, K. Hoshino, T. Kaisho, H. Sanjo, O. Takeuchi, M. Sugiyama, M. Okabe, K. Takeda, and S. Akira. 2003. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301: 640-643.
26. Kawai, T., O. Adachi, T. Ogawa, K. Takeda, and S. Akira. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115-122.
27. Li, Y., R. Si, Y. Feng, H. H. Chen, L. Zou, E. Wang, M. Zhang, H. S. Warren, D. E. Sosnovik, and W. Chao. 2011. Myocardial ischemia activates an injurious innate immune signaling via cardiac heat shock protein 60 and Toll-like receptor 4. J. Biol. Chem. 286: 31308-31319.
28. Zou, L., Y. Feng, M. Zhang, Y. Li, and W. Chao. 2011. Nonhematopoietic toll-like receptor 2 contributes to neutrophil and cardiac function impairment during polymicrobial sepsis. Shock 36: 370-380.
29. Rittirsch, D., M. S. Huber-Lang, M. A. Flierl, and P. A. Ward. 2009. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat. Protoc. 4: 31-36.
30. Thurman, J. M., D. M. Kraus, G. Girardi, D. Hourcade, H. J. Kang, P. A. Royer, L. M. Mitchell, P. C. Giclas, J. Salmon, G. Gilkeson, and V. M. Holers. 2005. A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice. Mol. Immunol. 42: 87-97.
31. Leinhase, I., M. Rozanski, D. Harhausen, J. M. Thurman, O. I. Schmidt, A. M. Hossini, M. E. Taha, D. Rittirsch, P. A. Ward, V. M. Holers, et al. 2007. Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti-factor B antibody: a randomized placebo-controlled study in mice. J. Neuroinflammation 4: 13.
32. Quigg, R. J., Y. Kozono, D. Berthiaume, A. Lim, D. J. Salant, A. Weinfeld, P. Griffin, E. Kremmer, and V. M. Holers. 1998. Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor. J. Immunol. 160: 4553-4560.
33. Morgan, B. P., and P. Gasque. 1997. Extrahepatic complement biosynthesis: where, when and why? Clin. Exp. Immunol. 107: 1-7.
34. Farrar, C. A., W. Zhou, T. Lin, and S. H. Sacks. 2006. Local extravascular pool of C3 is a determinant of postischemic acute renal failure. FASEB J. 20: 217-226.
35. Vieyra, M. B., and P. S. Heeger. 2010. Novel aspects of complement in kidney injury. Kidney Int. 77: 495-499.
36. Verschoor, A., M. A. Brockman, M. Gadjeva, D. M. Knipe, and M. C. Carroll. 2003. Myeloid C3 determines induction of humoral responses to peripheral herpes simplex virus infection. J. Immunol. 171: 5363-5371.
37. Lambris, J. D., Z. Lao, T. J. Oglesby, J. P. Atkinson, C. E. Hack, and J. D. Becherer. 1996. Dissection of CR1, factor H, membrane cofactor protein, and factor B binding and functional sites in the third complement component. J. Immunol. 156: 4821-4832.
38. Uchino, S., J. A. Kellum, R. Bellomo, G. S. Doig, H. Morimatsu, S. Morgera, M. Schetz, I. Tan, C. Bouman, E. Macedo, et al. 2005. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294: 813-818.
39. Doi, K., A. Leelahavanichkul, P. S. Yuen, and R. A. Star. 2009. Animal models of sepsis and sepsis-induced kidney injury. J. Clin. Invest. 119: 2868-2878.
40. Zarjou, A., and A. Agarwal. 2011. Sepsis and acute kidney injury. J. Am. Soc. Nephrol. 22: 999-1006.
41. Zhang, Z., B. D. Humphreys, and J. V. Bonventre. 2007. Shedding of the urinary biomarker kidney injury molecule-1 (KIM-1) is regulated by MAP kinases and juxtamembrane region. J. Am. Soc. Nephrol. 18: 2704-2714.
42. Siew, E. D., L. B.Ware, T. Gebretsadik, A. Shintani, K. G. Moons, N.Wickersham, F. Bossert, and T. A. Ikizler. 2009. Urine neutrophil gelatinase-associated lipocalin moderately predicts acute kidney injury in critically ill adults. J. Am. Soc. Nephrol. 20: 1823-1832.
43. Paragas, N., A. Qiu, Q. Zhang, B. Samstein, S. X. Deng, K. M. Schmidt-Ott, M. Viltard, W. Yu, C. S. Forster, G. Gong, et al. 2011. The Ngal reporter mouse detects the response of the kidney to injury in real time. Nat. Med. 17: 216-222.
44. Devarajan, P. 2010. Review: neutrophil gelatinase-associated lipocalin: a troponin-like biomarker for human acute kidney injury. Nephrology (Carlton) 15: 419-428.
45. Bosmann, M., and P. A. Ward. 2013. The inflammatory response in sepsis. Trends Immunol. 34: 129-136.
46. Hotchkiss, R. S., K. C. Chang, P. E. Swanson, K. W. Tinsley, J. J. Hui, P. Klender, S. Xanthoudakis, S. Roy, C. Black, E. Grimm, et al. 2000. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat. Immunol. 1: 496-501.
47. Naik, E., and V. M. Dixit. 2011. Mitochondrial reactive oxygen species drive proinflammatory cytokine production. J. Exp. Med. 208: 417-420.
48. Crimi, E., V. Sica, A. S. Slutsky, H. Zhang, S. Williams-Ignarro, L. J. Ignarro, and C. Napoli. 2006. Role of oxidative stress in experimental sepsis and multisystem organ dysfunction. Free Radic. Res. 40: 665-672.
49. Bayir, H. 2005. Reactive oxygen species. Crit. Care Med. 33: S498-S501.
50. Atkinson, C., H. Song, B. Lu, F. Qiao, T. A. Burns, V. M. Holers, G. C. Tsokos, and S. Tomlinson. 2005. Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection. J. Clin. Invest. 115: 2444-2453.
51. Weighardt, H., S. Kaiser-Moore, R. M. Vabulas, C. J. Kirschning, H. Wagner, and B. Holzmann. 2002. Cutting edge: myeloid differentiation factor 88 deficiency improves resistance against sepsis caused by polymicrobial infection. J. Immunol. 169: 2823-2827.
52. Feng, Y., L. Zou, M. Zhang, Y. Li, C. Chen, and W. Chao. 2011. MyD88 and Trif signaling play distinct roles in cardiac dysfunction and mortality during endotoxin shock and polymicrobial sepsis. Anesthesiology 115: 555-567.
53. Harboe, M., and T. E. Mollnes. 2008. The alternative complement pathway revisited. J. Cell. Mol. Med. 12: 1074-1084.
54. Sheerin, N. S., P. Risley, K. Abe, Z. Tang, W. Wong, T. Lin, and S. H. Sacks. 2008. Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury. FASEB J. 22: 1065-1072.
55. Schepp-Berglind, J., C. Atkinson, M. Elvington, F. Qiao, P. Mannon, and S. Tomlinson. 2012. Complement-dependent injury and protection in a murine model of acute dextran sulfate sodium-induced colitis. J. Immunol. 188: 6309-6318.
56. Windbichler, M., B. Echtenacher, T. Hehlgans, J. C. Jensenius, W. Schwaeble, and D. N. Mannel. 2004. Involvement of the lectin pathway of complement activation in antimicrobial immune defense during experimental septic peritonitis. Infect. Immun. 72: 5247-5252.
57. Ward, P. A. 2004. The dark side of C5a in sepsis. Nat. Rev. Immunol. 4: 133-142.
58. Czermak, B. J., V. Sarma, C. L. Pierson, R. L. Warner, M. Huber-Lang, N. M. Bless, H. Schmal, H. P. Friedl, and P. A. Ward. 1999. Protective effects of C5a blockade in sepsis. Nat. Med. 5: 788-792.
59. Huber-Lang, M., V. J. Sarma, K. T. Lu, S. R. McGuire, V. A. Padgaonkar, R. F. Guo, E. M. Younkin, R. G. Kunkel, J. Ding, R. Erickson, et al. 2001. Role of C5a in multiorgan failure during sepsis. J. Immunol. 166: 1193-1199.
60. Dahlke, K., C. D. Wrann, O. Sommerfeld, M. Sossdorf, P. Recknagel, S. Sachse, S. W. Winter, A. Klos, G. L. Stahl, Y. X. Ma, et al. 2011. Distinct different contributions of the alternative and classical complement activation pathway for the innate host response during sepsis. J. Immunol. 186: 3066-3075.
61. Xu, Y.,M. Ma, G. C. Ippolito, H.W. Schroeder, Jr.,M. C. Carroll, and J. E. Volanakis. 2001. Complement activation in factor D-deficient mice. Proc. Natl. Acad. Sci. USA 98: 14577-14582.